<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CAPSAICIN</span><br/>(cap-say'i-sin)<br/><span class="topboxtradename">Axsain, </span><span class="topboxtradename">Capsaicin, </span><span class="topboxtradename">Capsin, </span><span class="topboxtradename">Capsacin-P, </span><span class="topboxtradename">Dolorac, </span><span class="topboxtradename">Zostrix, </span><span class="topboxtradename">Zostrix-HP<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">topical analgesic</span><br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.025%, 0.075% lotion; 0.025%, 0.075%, 0.25% cream; 0.025%, 0.05% gel</p>
<h1><a name="action">Actions</a></h1>
<p>Capsaicin is an alkaloid derived from plants and is the active ingredient in hot peppers. It is used as a topical analgesic.
         Capsaicin's precise mechanism is not fully understood. Substance P is thought to act as a principal neurotransmitter of pain
         sensations from the peripheral neurons to the CNS.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It is thought that the drug renders skin and joints insensitive to pain by preventing the reaccumulation of substance P in
         peripheral sensory neurons. Thus capsaicin is an effective peripheral analgesic.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Temporary relief of pain from arthritis, neuralgias, diabetic neuropathy, and herpes zoster.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Phantom limb pain, psoriasis, intractable pruritus.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to capsaicin or any ingredient in the cream.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Patients on ACE inhibitors. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Analgesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply to affected area not more than 34 times/d<br/><span class="rdage">Child <img src="../images/special/greaterorequal.gif"/>2 y:</span> <span class="rdroute">Topical</span> Apply to affected area not more than 34 times/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Apply to affected areas only and avoid contact with eyes or broken or irritated skin.</li>
<li>If applied with bare hand, wash immediately following application. An applicator or gloved hand may be used to apply cream.</li>
<li>Avoid tight bandages over areas of application of the cream.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Concentration &gt;1%: neurotoxicity, hyperalgesia. <span class="typehead">Skin:</span>
<span class="speceff-common">Burning, stinging, redness,</span> itching. <span class="typehead">Other:</span> Cough. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May increase incidence of cough with <span class="classification">ace inhibitors</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> Postherpetic neuralgia: 26 wk. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for significant pain relief, which may require 46 wk of application three or four times daily.</li>
<li>Monitor for and report signs of skin breakdown as these generally indicate need for drug discontinuation.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report local discomfort at site of application if discomfort is distressing or persists beyond the first 34 d of use.</li>
<li>Use caution in handling contact lenses following application of cream. Wash hands thoroughly before touching lenses.</li>
<li>Notify physician if symptoms do not improve or condition worsens within 1428 d.</li>
<li>Apply frequently three or four times daily to maximize therapeutic effectiveness.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>